NeuroMetrix Announces Availability of Quell in Approximately 1,000 Chain Drug Stores

WALTHAM, Mass.–(BUSINESS WIRE)–$NURO #chronicpain–NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell®
will be available, beginning in June 2016, in approximately 1,000 chain
drug stores as part of a retail test with the two largest US drug

“Consumers have told us that they expect to see and purchase Quell at
leading chain drug stores,” said Shai N. Gozani, M.D., Ph.D., President
and CEO of NeuroMetrix. “We are therefore delighted to broaden the
availability of Quell, our proprietary, 100% drug free technology for
the relief of widespread chronic pain. As Quell represents a new level
of technology at premium pricing we will use learning from this test to
optimize our full retail expansion.”

Quell is FDA cleared and designed for millions of people suffering from
chronic pain. Quell gives users the option to start, stop, and adjust
therapy discreetly via their smartphone. It also enables advanced sleep
tracking that provides feedback on eight dimensions of sleep including
sleep duration, quality, body position, time out of bed, and repetitive
leg movements throughout the night. Quell is available at select
healthcare professionals and retailers. To find a Quell retailer near
you, visit the Store

About Quell

Quell utilizes NeuroMetrix’s patented neurostimulation technology to
provide widespread relief from chronic pain. The advanced wearable
device is lightweight and can be worn during the day while active, and
at night while sleeping. It has been cleared by the FDA for treatment of
chronic pain without a prescription. In a recent study, 81% of Quell
users reported an improvement in their chronic pain. Quell includes a
smartphone app that tracks and personalizes their pain therapy. Quell
was recently awarded the Innovation Award at SXSW for best Wearable
Technology. It is available for purchase at, selected
retailers and healthcare professionals.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit


NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer